AstraZeneca started at buy at Goldman, which rates GSK a neutral
Source: MarketWatch / 21 Dec 2023 20:44:53 America/New_York
Goldman Sachs started coverage of AstraZeneca at buy as it rated rival GSK a neutral.
https://www.marketwatch.com/story/astrazeneca-started-at-buy-at-goldman-which-rates-gsk-a-neutral-93c95b7f?mod=mw_rss_topstories